Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial
Authors:
- Andrew I R MaasAMAndrew I R Maas
- Gordon MurrayGMGordon Murray
- Herbert HenneyHHHerbert Henney
- Nadim KassemNKNadim Kassem
- Valerie LegrandVLValerie Legrand
- Miriam MangelusMMMiriam Mangelus
- Jan-Paul MuizelaarJMJan-Paul Muizelaar
- Nino StocchettiNSNino Stocchetti
- Nachshon KnollerNKNachshon Knoller
- Pharmos TBI investigatorsPIPharmos TBI investigators
- 1 January 2006
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (1) , 38-45
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Predicting Outcome after Traumatic Brain Injury: Development and Validation of a Prognostic Score Based on Admission CharacteristicsJournal of Neurotrauma, 2005
- Design and Analysis of Phase III Trials with Ordered Outcome Scales: The Concept of the Sliding DichotomyJournal of Neurotrauma, 2005
- Pathophysiology of Cerebral Ischemia and Brain Trauma: Similarities and DifferencesJournal of Cerebral Blood Flow & Metabolism, 2004
- Structured Interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for Their UseJournal of Neurotrauma, 1998
- Measuring the Long-Term Outcomes of Traumatic Brain Injury: A Review of the Community Integration QuestionnaireJournal of Head Trauma Rehabilitation, 1997
- EBIC-Guidelines for management of severe head injury in adultsActa Neurochirurgica, 1997
- The Barthel ADL Index: A reliability studyInternational Disability Studies, 1988
- Cerebral protectionJournal of Neurosurgery, 1986
- Absent or compressed basal cisterns on first CT scan: ominous predictors of outcome in severe head injuryJournal of Neurosurgery, 1984
- Adverse reactions to intravenous anaesthetic induction agents.BMJ, 1977